 Mass High Tech |
Lexington's GI Dynamics wins FDA OK for diabetes treatment trial
Boston Herald Lexington-based GI Dynamics Inc. said today it has received conditional approval from the U.S. Food and Drug Administration to begin a pivotal clinical trial of its EndoBarrier device to treat patients with Type 2 diabetes, and those who are obese. GI Dynamics gets FDA conditional OK for a trial of its EndoBarrier obesity …Boston Globe GI DYNAMICS INC : GI Dynamics, Inc. Announces FDA Conditional Approval for …4-traders GI Dynamics gets FDA OK for clinical trialMass High Tech Australian Life Scientist all 11 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.